Eddie Cliff

Eddie Cliff: Accelerated approval is a useful program but has a long way to go to ensure it delivers high-value drugs

Eddie Cliff, 

“Delighted to present our work at AACR24 today, led by Ian Liu, on oncology accelerated approvals, simultaneously published at JAMA.

Accelerated approval is a useful program but has a long way to go to ensure it delivers high-value drugs.”

Eddie Cliff: Accelerated approval is a useful program but has a long way to go to ensure it delivers high-value drugs

Read further.
Source: Eddie Cliff/X

AACR AACR24 cancer Eddie Cliff Ian Liu JAMA OncoDaily Oncology oncology accelerated approvals